Hypertension Management in Family Practice
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03579108|
Recruitment Status : Recruiting
First Posted : July 6, 2018
Last Update Posted : May 20, 2021
High blood pressure is the greatest threat to the global burden of disease, contributing to an estimated 9.4 million deaths a year. Cardiovascular disease morbidity and mortality are positively correlated with the degree of elevation of blood pressure, without any evidence of a threshold down to at least 115/75 mm Hg. Hypertension is common, and nearly every clinician in every specialty deals either directly or indirectly with managing it or its consequences.
The population age 65 years or older numbered 46.2 million in 2014 and they represent 14.5% of the US population, the older population in 2030 is projected to be more than twice as large as in 2000, growing from 35 million to 74 million and representing 21 percent of the total U.S. population and it is expected to more than double to 98 million in 2060.Proper managing and controlling blood pressure markedly improves patient morbidity and mortality, SHEP study showed that in persons aged 60 years and over with isolated systolic hypertension, antihypertensive stepped-care drug treatment with low-dose chlorthalidone as step 1 medication reduced the incidence of total stroke by 36%.This study will estimate the prevalence of hypertension diagnosis, treatment and outcomes in a Family Practice population. It is a hypothesis generating study
|Condition or disease||Intervention/treatment|
|Hypertension||Other: Retrospective Chart Review|
This a retrospective cross-sectional chart review study. The study population will consist of a random sample of patients from the Family Practice of the LSU Department of Family Medicine at LSU Health Sciences Center in New Orleans (LSUHSC-NO) Chart data will be collected retrospectively back to one year from date of starting data abstraction.
Data Quality The data used in this study comes from patient charts that are actively being used in the management of patient care. Data quality will be ensured through several means. First, the data collection process will be conducted family medicine resident. Second, data will be abstracted directly into an electronic encrypted Excel file.
Selection of Participants The family medicine residents will take each one 25 patients each and review the charts and record the information on an Excel spread sheet.
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Hypertension Management and Outcomes in a Family Practice Setting|
|Actual Study Start Date :||February 24, 2018|
|Estimated Primary Completion Date :||May 1, 2024|
|Estimated Study Completion Date :||August 31, 2024|
- Other: Retrospective Chart Review
Chart reviewOther Name: Chart review
- controlled hypertension [ Time Frame: 3 months ]number of patients controlled and non controlled
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03579108
|Contact: Erwin A Aguilar, PharmD,, MPHemail@example.com|
|Contact: Sean Barry, BScfirstname.lastname@example.org|
|United States, Louisiana|
|LSU Health Sciences Center||Recruiting|
|New Orleans, Louisiana, United States, 70112|
|Contact: Erwin Aguilar, PharmD 504-568-8655 email@example.com|
|Contact: Sean Barry, BSc 504-568-8655 firstname.lastname@example.org|
|Principal Investigator: Erwin A Aguilar, PharmD|
|Sub-Investigator: Sean Barry, BSc|
|Principal Investigator:||Erwin A Aguilar, PharmD, MPH||LSU Health Sciences Center in New Orleans|